Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.

Expert review of molecular diagnostics - 1 Jun 2020

Shimazawa Rumiko, Ikeda Masayuki

Abstract excerpt

INTRODUCTION: The 'one biomarker/one drug' scenario is unsustainable because cancer is a complex disorder that involves a number of molecular defects. In the past decade, major technological advances have lowered the overall cost and increased the efficiency of next-generation sequencing (NGS). AREAS COVERED: We review recent regulations on NGS and complementary diagnostics in Japan, mainly focusing on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Databases, Nucleic Acid
Share to Genetic Diseases, Inborn

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Health Services Needs and Demand

Share to Immune Checkpoint Inhibitors

Share to Molecular Diagnostic Techniques

Share to Molecular Targeted Therapy

Share to National Health Programs

Source

Identifiers

PMID: 32064968
DOI: 10.1080/14737159.2020.1728256

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.PMID 32064968Read ↗

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical OncologySemantic proximity Read ↗

[Standardization of next-generation sequencing for detecting mutations associated with targeted therapy and immunotherapy based on dynamic pattern of expandable detection range].Semantic proximity Read ↗

The emerging roles of NGS in clinical oncology and personalized medicine.Semantic proximity Read ↗

New Era for Next-Generation Sequencing in JapanSemantic proximity Read ↗

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologiesSemantic proximity Read ↗

Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid BiopsySemantic proximity Read ↗

Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.Semantic proximity Read ↗

[Current Status and Regulatory Issues of Companion Diagnostics in Japan].Semantic proximity Read ↗

Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directionsSemantic proximity Read ↗

Targeted therapy according to next generation sequencing-based panel sequencingSemantic proximity Read ↗

Next-Generation Sequencing in Cancer Diagnosis and TreatmentSemantic proximity Read ↗

Next-Generation Sequencing in Cancer Diagnosis and TreatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.